Incyte to Present at the Cowen and Company 30th Annual Health Care Conference

Incyte Corporation (Nasdaq:INCY) announced today it will present at the Cowen and Company 30th Annual Health Care Conference on Monday, March 8, 2010 at 3:15 p.m. ET. Presenting for Incyte Corporation will be Paul Friedman, M.D., president and chief executive officer.

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology, inflammation and diabetes. Incyte’s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at www.incyte.com.

Incyte (NASDAQ:INCY)
Historical Stock Chart
From May 2024 to Jun 2024